Bluestar Adds Dedicated Medical Silicone Capacity
Device and pharmaceutical tubing makers in Europe gain a dedicated, compliance-focused silicone supply line.
Updated on Nov. 6, 2026 in Healthcare

Bluestar Silicones has allocated dedicated production capacity in Europe for medical grade high consistency silicone rubber used in pharmaceutical tubing and fluid transfer applications. The company has also implemented targeted equipment upgrades and qualification measures for healthcare production.
Why it matters
Medical-grade silicone is qualified under strict biocompatibility and extractables testing, so dedicated, controlled capacity matters to device makers that need consistent supply of compliant materials. Separating healthcare production from general industrial output reduces contamination risk for buyers in regulated markets.
No numerical capacity, volume, or financial figures were disclosed for the allocation. The announcement covers platinum-cured polyaddition silicone grades produced on existing industrial-scale assets in Europe.
The players
Bluestar Silicones
Bluestar Silicones is a silicone materials producer whose healthcare portfolio serves medical tubing, drug delivery, diagnostics, wound care, and wearable healthcare products.
The details
The allocated capacity is built on Bluestar Silicones' High Consistency Rubber platform and is dedicated to platinum-cured polyaddition grades for pharmaceutical tubing and fluid transfer. The company says it invested in equipment upgrades, dedicated cleaning and validation procedures, and operational safeguards to minimize contamination risk. Materials are designed to meet healthcare qualification requirements, including biocompatibility assessments and extractable and leachable testing.
Timeline
No specific announcement or production start date was provided in the source.
Market Landscape
The move reflects a broader pattern in which silicone suppliers separate medical-grade production from industrial lines to meet healthcare qualification demands. It positions Bluestar's HCR platform against other European and global medical silicone producers competing on compliance-ready supply.
Device and pharmaceutical manufacturers sourcing medical silicone should factor in dedicated capacity when reviewing supplier qualification and continuity plans. Procurement teams may want to confirm biocompatibility and extractables documentation with qualified regulatory counsel before changing suppliers.
The takeaway
Operators sourcing medical-grade silicone should ask suppliers for documentation on dedicated capacity, cleaning validation, and biocompatibility testing before the next qualification cycle. Track whether competing suppliers announce similar segregated healthcare lines.
Further reading
For broader context on how healthcare suppliers manage regulated materials, explore our Healthcare coverage.
Source note: This article includes information reported by Rubber Journal Asia -News on Rubber machinery , Manufacturers , Rubber chemical producers and Rubber processors.


